[SCHEDULE 13G] MDA Space Ltd. Passive Investment Disclosure (>5%)
MDA Space: Morgan Stanley reports 8.8% stake
The reporting parties list shared voting and disposition authority separately, and Morgan Stanley says certain disaggregated operating units are excluded.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
MDA Space Ltd. is the issuer for a Schedule 13G in which Morgan Stanley reports beneficial ownership of 14,290,181 common shares, or 8.8%, as of September 30, 2026. Morgan Stanley Canada Limited separately reports 14,177,235 common shares, or 8.7%.
Morgan Stanley lists shared voting power over 14,245,690 shares and shared dispositive power over 14,289,885 shares. Morgan Stanley Canada Limited lists shared voting and shared dispositive power over 14,177,235 shares each. Morgan Stanley says the report reflects securities held or deemed held by certain operating units and excludes units whose holdings are disaggregated under the cited SEC release.
Key Figures
Morgan Stanley beneficial ownership:14,290,181 sharesMorgan Stanley beneficial ownership percentage:8.8%Morgan Stanley shared voting power:14,245,690 shares+5 more
8 metrics
Morgan Stanley beneficial ownership14,290,181 sharesAs of September 30, 2026
Morgan Stanley beneficial ownership percentage8.8%MDA common shares
Morgan Stanley shared voting power14,245,690 sharesMDA common shares
Morgan Stanley shared dispositive power14,289,885 sharesMDA common shares
Morgan Stanley Canada Limited beneficial ownership14,177,235 sharesAs of September 30, 2026
Morgan Stanley Canada Limited beneficial ownership percentage8.7%MDA common shares
Morgan Stanley Canada Limited shared voting power14,177,235 sharesMDA common shares
Morgan Stanley Canada Limited shared dispositive power14,177,235 sharesMDA common shares
Key Terms
beneficially owned, Shared Voting Power, Shared Dispositive Power
3 terms
beneficially ownedregulatory
"Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Powerregulatory
"Shared Voting Power 14,245,690.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 14,289,885.00"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many MDA shares did Morgan Stanley report owning?
Morgan Stanley reported beneficial ownership of 14,290,181 MDA common shares, representing 8.8%, as of September 30, 2026.
How many MDA shares did Morgan Stanley Canada Limited report owning?
Morgan Stanley Canada Limited reported beneficial ownership of 14,177,235 MDA common shares, representing 8.7%, as of September 30, 2026.
Which Morgan Stanley operating units are reflected in the MDA 13G?
Morgan Stanley says the report reflects securities beneficially owned, or that may be deemed beneficially owned, by certain operating units of Morgan Stanley and its subsidiaries and affiliates. It excludes securities beneficially owned by operating units whose ownership is disaggregated under the cited SEC release.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
MDA Space Ltd.
(Name of Issuer)
Common Shares
(Title of Class of Securities)
55293N109
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
55293N109
1
Names of Reporting Persons
Morgan Stanley
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
14,245,690.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
14,289,885.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
14,290,181.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.8 %
12
Type of Reporting Person (See Instructions)
HC, CO
SCHEDULE 13G
CUSIP Number(s):
55293N109
1
Names of Reporting Persons
Morgan Stanley Canada Limited
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CANADA (FEDERAL LEVEL)
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
14,177,235.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
14,177,235.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
14,177,235.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.7 %
12
Type of Reporting Person (See Instructions)
BD, FI, CO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
MDA Space Ltd.
(b)
Address of issuer's principal executive offices:
7500 FINANCIAL DRIVE, BRAMPTON, A6, L6Y 6K7
Item 2.
(a)
Name of person filing:
1: Morgan Stanley 2: Morgan Stanley Canada Limited
(b)
Address or principal business office or, if none, residence:
1: 1585 Broadway, New York, NY 10036 ;2: 181 Bay Street Suite 3700, Toronto M5J 2T3, Canada
(c)
Citizenship:
1: Delaware 2: Canada
(d)
Title of class of securities:
Common Shares
(e)
CUSIP Number(s):
55293N109
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to a broker or dealer registered under section 15 of the Act (15 U.S.C. 78o) is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.
Item 4.
Ownership
(a)
Amount beneficially owned:
See the response(s) to Item 9 on the attached cover page(s).
(b)
Percent of class:
8.8 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See the response(s) to Item 5 on the attached cover page(s).
(ii) Shared power to vote or to direct the vote:
See the response(s) to Item 6 on the attached cover page(s).
(iii) Sole power to dispose or to direct the disposition of:
See the response(s) to Item 7 on the attached cover page(s).
(iv) Shared power to dispose or to direct the disposition of:
See the response(s) to Item 8 on the attached cover page(s).
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Exhibit 99.2
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to a broker or dealer registered under section 15 of the Act (15 U.S.C. 78o) is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.
* In Accordance with the Securities and Exchange Commission Release
No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the
securities beneficially owned, or that may be deemed to be beneficially owned,
by certain operating units (collectively, the "MS Reporting Units") of Morgan
Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing
does not reflect securities, if any, beneficially owned by any operating units
of MS whose ownership of securities is disaggregated from that of the MS
Reporting Units in accordance with the Release.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Morgan Stanley
Signature:
Claire Gordon
Name/Title:
Authorized Signatory, Morgan Stanley
Date:
11/06/2026
Morgan Stanley Canada Limited
Signature:
Claire Gordon
Name/Title:
Authorized Signatory, Morgan Stanley Canada Limited
Date:
11/06/2026
Exhibit Information
EXHIBIT NO. EXHIBITS
------------------ ------------------------------------
99.1 Joint Filing Agreement
99.2 Item 7 Information
* Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
